InnovAge Holding Corp. (INNV): Price and Financial Metrics

InnovAge Holding Corp. (INNV): $6.89

0.17 (+2.53%)

POWR Rating

Component Grades














  • INNV scores best on the Stability dimension, with a Stability rank ahead of 90.18% of US stocks.
  • INNV's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • INNV's current lowest rank is in the Growth metric (where it is better than 2.89% of US stocks).

INNV Stock Summary

  • INNV's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.52 -- higher than only 4.68% of US-listed equities with positive expected earnings growth.
  • INNOVAGE HOLDING CORP's stock had its IPO on March 4, 2021, making it an older stock than merely 6.9% of US equities in our set.
  • Over the past twelve months, INNV has reported earnings growth of -298.43%, putting it ahead of just 5.57% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to INNOVAGE HOLDING CORP are SSNT, MATW, AEY, ODP, and LCUT.
  • To dig deeper into the stock's financial statements, go to INNV's page on browse-edgar?action=getcompany&CIK=0001834376.

INNV Valuation Summary

  • INNV's price/sales ratio is 1.3; this is 73.2% lower than that of the median Healthcare stock.
  • INNV's price/earnings ratio has moved down 259.7 over the prior 20 months.

Below are key valuation metrics over time for INNV.

Stock Date P/S P/B P/E EV/EBIT
INNV 2022-11-01 1.3 2.7 -137.0 -242.6
INNV 2022-10-31 1.2 2.5 -128.7 -226.0
INNV 2022-10-28 1.2 2.5 -127.2 -223.1
INNV 2022-10-27 1.2 2.4 -124.1 -216.9
INNV 2022-10-26 1.2 2.5 -125.1 -219.0
INNV 2022-10-25 1.1 2.3 -119.1 -207.0

INNV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INNV has a Quality Grade of C, ranking ahead of 68.28% of graded US stocks.
  • INNV's asset turnover comes in at 1.355 -- ranking 10th of 81 Healthcare stocks.
  • 500 - Internal server error

The table below shows INNV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.355 0.273 -0.067

INNV Price Target

For more insight on analysts targets of INNV, see our INNV price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $26.00 Average Broker Recommendation 1.64 (Moderate Buy)

INNV Stock Price Chart Interactive Chart >

Price chart for INNV

INNV Price/Volume Stats

Current price $6.89 52-week high $9.15
Prev. close $6.72 52-week low $3.39
Day low $6.64 Volume 31,900
Day high $7.02 Avg. volume 204,641
50-day MA $6.05 Dividend yield N/A
200-day MA $5.17 Market Cap 934.08M

InnovAge Holding Corp. (INNV) Company Bio

InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. It offers interdisciplinary care teams and community-based care delivery models. It operates through the PACE and All Other segments. The PACE segment consists of the West, Central, and East operations. The All Other segment consists of homecare and senior housing. The company was founded in 2007 and is headquartered in Denver, CO.

INNV Latest News Stream

Event/Time News Detail
Loading, please wait...

INNV Latest Social Stream

Loading social stream, please wait...

View Full INNV Social Stream

Latest INNV News From Around the Web

Below are the latest news stories about INNOVAGE HOLDING CORP that investors may wish to consider to help them evaluate INNV as an investment opportunity.

InnovAge Announces Release of CMS Sanction in Sacramento Center

DENVER, Nov. 22, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced today that the Centers for Medicare & Medicaid Services (CMS) has determined that effective immediately the sanction is released from InnovAge in Sacramento, California and it will return to normal enrollment status for Medicare-eligible participants. The California Department of Health Care Se

Yahoo | November 22, 2022

Feds begin audit that could lead to end of sanctions on Denver health company

Colorado has not begun a similar and needed audit, however, leading to uncertainty on the time frame for sanctions possibly being lifted.

Yahoo | November 10, 2022

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Lags Revenue Estimates

InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -150% and 1.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 9, 2022

InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2022

DENVER, Nov. 08, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal first quarter ended September 30, 2022. “We have continued to make solid progress this quarter on our regulatory and operational priorities and are now beginning to look forward to the time when we can serve more deserving seniors with the PACE model,” said Patr

Yahoo | November 8, 2022

Earnings Preview: Doximity (DOCS) Q2 Earnings Expected to Decline

Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | November 3, 2022

Read More 'INNV' Stories Here

INNV Price Returns

1-mo 15.41%
3-mo 77.58%
6-mo N/A
1-year -9.46%
3-year 478.99%
5-year -22.80%
YTD 37.80%
2021 N/A
2020 0.00%
2019 -87.41%
2018 -19.40%
2017 -57.93%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6335 seconds.